Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Unn miriam Kasti"'
Autor:
Jens Overgaard, M.H. Nielsen, Unn miriam Kasti, Mechthild Krause, Andreas Schreiber, Birgitte Vrou Offersen, Ingvil Mjaaland, Lars Stenbygaard, Jan Alsner, Erik Jakobsen, Hanne Melgaard Nielsen
Publikováno v:
Offersen, B V, Alsner, J, Nielsen, H M, Jakobsen, E H, Nielsen, M H, Krause, M, Stenbygaard, L, Mjaaland, I, Schreiber, A, Kasti, U M, Overgaard, J & Danish Breast Cancer Group Radiation Therapy Committee 2020, ' Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial : The DBCG HYPO Trial ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 38, no. 31, pp. 3615-3625 . https://doi.org/10.1200/JCO.20.01363
Journal of Clinical Oncology 38(2020)31, 3615
Offersen, B V, Alsner, J, Nielsen, H M, Jakobsen, E H, Nielsen, M H, Krause, M, Stenbygaard, L, Mjaaland, I, Schreiber, A, Kasti, U M, Overgaard, J & Danish Breast Cancer Group Radiation Therapy Committee 2020, ' Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial : The DBCG HYPO Trial ', Journal of Clinical Oncology, vol. 38, no. 31, pp. 3615-3625 . https://doi.org/10.1200/JCO.20.01363
Journal of Clinical Oncology 38(2020)31, 3615
Offersen, B V, Alsner, J, Nielsen, H M, Jakobsen, E H, Nielsen, M H, Krause, M, Stenbygaard, L, Mjaaland, I, Schreiber, A, Kasti, U M, Overgaard, J & Danish Breast Cancer Group Radiation Therapy Committee 2020, ' Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial : The DBCG HYPO Trial ', Journal of Clinical Oncology, vol. 38, no. 31, pp. 3615-3625 . https://doi.org/10.1200/JCO.20.01363
PURPOSE Given the poor results using hypofractionated radiotherapy for early breast cancer, a dose of 50 Gy in 25 fractions (fr) has been the standard regimen used by the Danish Breast Cancer Group (DBCG) since 1982. Results from more recent trials h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd0ab8429e8d52813445896f545e7193
https://portal.findresearcher.sdu.dk/da/publications/2c9d0b27-18b1-43c9-98e4-257a87e3c2d9
https://portal.findresearcher.sdu.dk/da/publications/2c9d0b27-18b1-43c9-98e4-257a87e3c2d9
Autor:
M.H. Nielsen, E.S. Yates, Ingelise Jensen, M.S. Thomsen, Giulio Francolini, Andreas Schreiber, Claus Kamby, Ingvil Mjaaland, Mechthild Krause, Unn miriam Kasti, Carine Kirkove, Birgitte Vrou Offersen, Martin Berg, Kristian Boye, Egil S. Blix
Publikováno v:
Francolini, G, Thomsen, M S, Yates, E S, Kirkove, C, Jensen, I, Blix, E S, Kamby, C, Nielsen, M H, Krause, M, Berg, M, Mjaaland, I, Schreiber, A, Kasti, U-M, Boye, K & Offersen, B V 2017, ' Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1 ', Radiotherapy & Oncology, vol. 123, no. 2, pp. 282-287 . https://doi.org/10.1016/j.radonc.2017.03.011
Francolini, G, Thomsen, M S, Yates, E S, Kirkove, C, Jensen, I, Blix, E S, Kamby, C, Holck Nielsen, M, Krause, M, Berg, M, Mjaaland, I, Schreiber, A, Kasti, U M, Boye, K & Offersen, B V 2017, ' Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1 ', Radiotherapy & Oncology, vol. 123, no. 2, pp. 282–287 . https://doi.org/10.1016/j.radonc.2017.03.011
Radiotherapy and Oncology 123(2017)2, 282-287
Francolini, G, Thomsen, M S, Yates, E S, Kirkove, C, Jensen, I, Blix, E S, Kamby, C, Holck Nielsen, M, Krause, M, Berg, M, Mjaaland, I, Schreiber, A, Kasti, U M, Boye, K & Offersen, B V 2017, ' Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1 ', Radiotherapy & Oncology, vol. 123, no. 2, pp. 282–287 . https://doi.org/10.1016/j.radonc.2017.03.011
Radiotherapy and Oncology 123(2017)2, 282-287
BACKGROUND AND PURPOSE:To report on a Quality assessment (QA) of Skagen Trial 1, exploring hypofractionation for breast cancer patients with indication for regional nodal radiotherapy.MATERIAL AND METHODS:Deviations from protocol regarding target vol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::722932441ef2127b204b36a74cb7f838
https://vbn.aau.dk/da/publications/d015e6d3-1c32-462f-b943-79b71b1138e0
https://vbn.aau.dk/da/publications/d015e6d3-1c32-462f-b943-79b71b1138e0
Autor:
Unn miriam Kasti, Carine Kirkove, Andreas Schreiber, Egil S. Blix, B. Offersen, M. Krause, Claus Kamby, Mette Møller Nielsen, Ingvil Mjaaland, Ingelise Jensen, Martin Berg, Giulio Francolini, E.S. Yates, Kit Boye, M.S. Thomsen
Publikováno v:
Radiotherapy and Oncology. 123:S490-S491
Autor:
B. Offersen, Hanne Melgaard Nielsen, M. B. Jensen, M.H. Nielsen, Lars Stenbygaard, E. H. Jacobsen, Ingvil Mjaaland, Andreas Schreiber, Jens Overgaard, M. Krause, Jan Alsner, Unn miriam Kasti
Publikováno v:
Radiotherapy and Oncology. 127:S312